Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets
- PMID: 24738947
- DOI: 10.1111/1440-1681.12238
Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets
Abstract
Reactive oxygen species (ROS), the cellular products of myriad physiological processes, have long been understood to lead to cellular damage if produced in excess and to be a causative factor in cancer through the oxidation and nitration of various macromolecules. Reactive oxygen species influence various hallmarks of cancer, such as cellular proliferation and angiogenesis, through the promotion of cell signalling pathways intrinsic to these processes and can also regulate the function of key immune cells, such as macrophages and regulatory T cells, which promote angiogenesis in the tumour environment. Herein we emphasize the family of NADPH oxidase enzymes as the most likely source of ROS, which promote angiogenesis and tumourigenesis through signalling pathways within endothelial, immune and tumour cells. In this review we focus on the pharmacological inhibitors of NADPH oxidases and suggest that, compared with traditional anti-oxidants, they are likely to offer better alternatives for suppression of tumour angiogenesis. Despite the emerging enthusiasm towards the use of NADPH oxidase inhibitors for cancer therapy, this field is still in its infancy; in particular, there is a glaring lack of knowledge of the roles of NADPH oxidases in in vivo animal models and in human cancers. Certainly a clearer understanding of the relevant signalling pathways influenced by NADPH oxidases during angiogenesis in cancer is likely to yield novel therapeutic approaches.
Keywords: NADPH oxidase; Nox; angiogenesis; cancer; cell proliferation; oxidative stress; reactive oxygen species; superoxide.
© 2014 Wiley Publishing Asia Pty Ltd.
Similar articles
-
NADPH oxidases as regulators of tumor angiogenesis: current and emerging concepts.Antioxid Redox Signal. 2012 Jun 1;16(11):1229-47. doi: 10.1089/ars.2011.4489. Epub 2012 Mar 23. Antioxid Redox Signal. 2012. PMID: 22229841 Review.
-
ROS signalling, NADPH oxidases and cancer.Biochem Soc Trans. 2014 Aug;42(4):934-8. doi: 10.1042/BST20140060. Biochem Soc Trans. 2014. PMID: 25109982 Review.
-
Balancing reactive oxygen species in the epigenome: NADPH oxidases as target and perpetrator.Antioxid Redox Signal. 2013 May 20;18(15):1937-45. doi: 10.1089/ars.2012.4895. Epub 2012 Nov 5. Antioxid Redox Signal. 2013. PMID: 23126619 Review.
-
Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor.Cancer Res. 2007 Nov 15;67(22):10823-30. doi: 10.1158/0008-5472.CAN-07-0783. Cancer Res. 2007. PMID: 18006827
-
[ROS and NADPH oxidase: key regulators of tumor vascularisation].Med Sci (Paris). 2014 Apr;30(4):415-21. doi: 10.1051/medsci/20143004016. Epub 2014 May 5. Med Sci (Paris). 2014. PMID: 24801037 Review. French.
Cited by
-
NOX2 oxidase expressed in endosomes promotes cell proliferation and prostate tumour development.Oncotarget. 2018 Oct 23;9(83):35378-35393. doi: 10.18632/oncotarget.26237. eCollection 2018 Oct 23. Oncotarget. 2018. PMID: 30459931 Free PMC article.
-
Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors.Curr Pharm Des. 2015;21(41):6023-35. doi: 10.2174/1381612821666151029112013. Curr Pharm Des. 2015. PMID: 26510437 Free PMC article. Review.
-
Differential Redox Regulation of Ca²⁺ Signaling and Viability in Normal and Malignant Prostate Cells.Biophys J. 2015 Oct 6;109(7):1410-9. doi: 10.1016/j.bpj.2015.08.006. Biophys J. 2015. PMID: 26445441 Free PMC article.
-
Extracellular Electrophysiology in the Prostate Cancer Cell Model PC-3.Sensors (Basel). 2019 Jan 3;19(1):139. doi: 10.3390/s19010139. Sensors (Basel). 2019. PMID: 30609788 Free PMC article.
-
Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK.Biomedicines. 2022 Jan 29;10(2):319. doi: 10.3390/biomedicines10020319. Biomedicines. 2022. PMID: 35203528 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources